Cancer-related pathways reveal potential treatment target for congenital heart disease

Cross-disciplinary teams of scientists studying genetic pathways that are mutated in many forms of cancer, but which also cause certain forms of congenital heart disease -- including hypertrophic cardiomyopathy, a thickening of the heart muscle that is the leading cause of sudden death in children and young adults, have introduced these mutations into mice and successfully treated HCM in the lab.

Read the whole article on Science Daily

More from Science Daily